AZN vs SMBC · P/E 28, $288.38B cap vs P/E 12, rev $70.6M
AstraZeneca PLC (AZN) versus Southern Missouri Bancorp Inc (SMBC) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Southern Missouri Bancorp Inc (SMBC) is a banks - regional company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported SMBC revenue for 2025-06-30 was $70.6M. Net income was $15.8M. SMBC currently screens at market cap $656.9M and trailing P/E 11.7.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. SMBC currently screens at market cap $656.9M and trailing P/E 11.7.
Not investment advice. Open the AZN and SMBC stock pages for the full models.
Not investment advice.